Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA)
| CAPS Rating |
|
|---|---|
| Open | $0.68 |
| Previous Close | $0.69 |
| Daily Range | $0.68 - $0.74 |
| 52-Week Range | $0.51 - $1.91 |
| Market Cap | $52.30M |
| P/E Ratio | 6.50 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 146,256 |
| Average Daily Volume | 0 |
ALXA
VS S&P 500 (SPY)
How do you think ALXA will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ALXA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ALXA News and Commentary
- 4 Biotechs Dominating the Week – The Motley Fool
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- CORRECT(12/13): FDA Panel Recommends Use Of Alexza Pharma's Bipolar Treatment – SmartMoney
- 3 Biotechs Making Big Moves on Big News – The Motley Fool
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- FDA Panel Recommends Use Of Alexza Pharma's Bipolar Treatment – SmartMoney
- Market Volatility = Biotech Opportunity – The Motley Fool
- Our Top Biotech Stock Idea – The Motley Fool
- Insomnia Found to Cost $63 Billion a Year - Here are 4 Companies to Treat It – NASDAQ
- 3 Stocks Approaching Greatness – The Motley Fool
- 3 Top Stocks at Half-Price – The Motley Fool
- Wall Street's Best Hidden Stocks – The Motley Fool
- Our Top Stock Idea – The Motley Fool
- The best hedges – Blog at The Motley Fool
- Dow Nears 2011 Highs – SeekingAlpha
- All Eyes on Alexza as Company Prepares to Re-File Drug Application – SeekingAlpha
- The Market Seems to Disagree With Alexza's Promising News – SeekingAlpha
- A New Deal for Alexza Could Present Opportunity for Investors – SeekingAlpha
- Biotech’s Top and Bottom 10 From 2010 – SeekingAlpha
RSS Headlines
Fool UK
